SYN-NAT
Live / Registered — Registered (as of 11 Mar 2025)
What this means for you
Registered since 11 Mar 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88912528
- Registration number
- 7724324
- Mark type
- Word mark
- Filed
- 12 May 2020
- Published for opposition
- 02 Apr 2024
- Registered
- 11 Mar 2025
- Attorney of record
- Timothy T. Wang
Goods and services
- Class 005 — Pharmaceuticals: Tonics of medicines, namely, medicinal tea; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in preventing prostatitis, benign prostatic hyperplasia, urinary tract infection, gynecological inflammation, gastrointestinal disease; Medicines for human purposes in the form of effervescent tablets, chewable tablet and chewing gum for use in blood sugar regulation, liver protection, and as antioxidants, anti-hyperlipidemia, anti-aging, antineoplastic and antiviral agents for medical use; Medicines for human purposes, namely, medicines for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Medicinal drinks; Capsules sold empty for pharmaceuticals; Pharmaceutical preparations for the treatment of gastrointestinal disease, skin disease, cardiovascular disease, gout, asthma, nasitis, prostatic cancer, leukemia, melanoma, brain glioma, colon cancer, cervical cancer, thyroid cancer, kidney cancer, stomach cancer and lung cancer, hepatitis B, hepatitis C, AIDS and influenza, prostatitis, benign prostatic hyperplasia and gynecological inflammation, diabetes, sleep disorder and rheumatoid arthritis; Chemico-pharmaceutical preparations for tumor-suppression and antiviral treatment; Troches, namely, tablets for use in tumor-suppression, as antivirals and for the treatment of chronic gastrointestinal disease; Tinctura in the nature of medicinal herb extracts; Herbs for medicinal purposes; Nutritional supplements; dietetic foods adapted for medical use, namely, dietetic drinks, dietetic crackers, dietetic sugar for medical use, dietetic sugar substitutes for medical use; Dietary and nutritional supplements; Dietary food supplements; Dietary supplemental drinks; Dietary supplements; Dietetic beverages adapted for medical use; Dietetic foods adapted for medical purposes; Dietetic foods and beverages adapted for medical use; Nutraceuticals for use as a dietary supplement; Nutritional supplements in the form of capsules, tablets, caplets, powder, syrups, gummies and gels; Sanitizing preparations for commercial use
Owner
- Medoncare Pharmaceutical Co., Ltd., Changsha, Hunan, CN
- Medoncare Pharmaceutical Co., Ltd., Changsha, Hunan, CN
- Medoncare Pharmaceutical Co., Ltd., Changsha, Hunan, CN
Prosecution history
- 11 Mar 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Mar 2025 — REGISTERED-PRINCIPAL REGISTER
- 15 Feb 2025 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 15 Feb 2025 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 14 Feb 2025 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Dec 2024 — USE AMENDMENT FILED
- 14 Feb 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 03 Dec 2024 — TEAS STATEMENT OF USE RECEIVED
- 04 Jun 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 02 Apr 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 02 Apr 2024 — PUBLISHED FOR OPPOSITION
- 13 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 29 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 29 Aug 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
- 01 Mar 2023 — REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED